| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/27/2013 | CN103002879A Microvesicles derived from cell protoplast, and use thereof |
| 03/27/2013 | CN102994466A Human protein NDUFA10 interacting with transgenic plant exogenous Bt protein |
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN102989018A Methods and compositions for diagnosis of IgA-and IgM-mediated kidney diseases |
| 03/27/2013 | CN102989016A Nanoparticle material with pH sensitivity and preparation method thereof |
| 03/27/2013 | CN102989015A Preparation method of CT imaging molecular probe of folate receptor targeted tumor |
| 03/27/2013 | CN102989014A Preparation method for CT (computed tomography) contrast media based on second-generation polyamide-amine dendrimer/gold nanoparticles |
| 03/27/2013 | CN102989013A Preparation method for lymphatic vessel recognized carbon nanosphere |
| 03/27/2013 | CN102988294A Preparation method of fluorocarbon compound liposome |
| 03/27/2013 | CN102552944B Nasopharyngeal carcinoma targeted magnetic resonance contrast agent and preparation method thereof |
| 03/27/2013 | CN102350002B Glioma-targeting molecule magnetic resonance contrast agent as well as preparation method and application thereof |
| 03/27/2013 | CN102225866B Preparation method for ferrite nano-particles |
| 03/27/2013 | CN101979605B Reporter gene labeled-mouse model for monitoring function of HBV specific CTLs in vivo and construction method and application thereof |
| 03/27/2013 | CN101928347B Anti-carcinoembryonic-antigen (CEA) antibody and application thereof |
| 03/27/2013 | CN101808670B Golden mean harmonized water and aqueous solutions |
| 03/27/2013 | CN101607985B Monoclonal antibody for anti-human CEA, a composition containing same and application thereof |
| 03/27/2013 | CN101437550B Real-time detection of influenza virus |
| 03/27/2013 | CN101355940B In vivo or in vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 03/27/2013 | CN101233117B Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 03/26/2013 | US8404826 Mycobacterial antigens expressed under low oxygen tension |
| 03/26/2013 | US8404215 Methods of therapeutic monitoring of nitrogen scavenging |
| 03/21/2013 | WO2013040494A1 Smarttm solid oral dosage forms |
| 03/21/2013 | WO2013038271A1 Fill formulations and capsules and method of use to avoid migration of fill into or through the shell |
| 03/21/2013 | WO2013037804A1 Method for monitoring cytotoxic t lymphocyte (ctl) responses by a delayed-type hypersensitivity reaction using defined ctl viral epitopes |
| 03/21/2013 | WO2013012754A9 Boron-based dual imaging probes, compositions and methods for rapid aqueous f-18 labeling, and imaging methods using same |
| 03/21/2013 | WO2013009701A3 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| 03/21/2013 | US20130072849 Use of green porphyrins to treat neovasculature in the eye |
| 03/21/2013 | US20130071440 Use of simple amino acids to form porous particles |
| 03/21/2013 | US20130071388 Method for treating psoriasis |
| 03/21/2013 | US20130071335 X-ray contrast media compositions and methods of using the same |
| 03/21/2013 | US20130071334 Method and system for identifying, assessing, and managing cancer disease |
| 03/21/2013 | US20130071333 Method and system for identifying, assessing, and managing cancer growth rates and potential metastasis |
| 03/21/2013 | US20130071332 Labeled molecular imaging agents and methods of use |
| 03/21/2013 | US20130071331 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof |
| 03/21/2013 | US20130071330 Methods of identifying agents effective to treat cognitive decline and diseases associated therewith |
| 03/21/2013 | US20130071329 Theranostic delivery systems with modified surfaces |
| 03/21/2013 | US20130071328 Propynoic Acid Carbamoyl Methyl-Amides and Pharmaceutical Compositions and Methods Based Thereon |
| 03/21/2013 | US20130071326 Universal cell-directed theranostics |
| 03/21/2013 | US20130071321 Delivery of agents to inflamed tissues using folate-targeted liposomes |
| 03/21/2013 | CA2845712A1 Smarttm solid oral dosage forms |
| 03/20/2013 | EP2570150A1 Ultrasonically visible balloon catheter assembly and method of imaging a medical balloon |
| 03/20/2013 | EP2569330A2 Chlorotoxin variants, conjugates, and methods for their use |
| 03/20/2013 | EP2569276A1 Novel cationic lipids and methods of use thereof |
| 03/20/2013 | EP2569019A2 Compositions, methods and systems for the synthesis and use of imaging agents |
| 03/20/2013 | CN102985114A X-ray imaging at low contrast agent concentrations and/or low dose radiation |
| 03/20/2013 | CN102978123A Immune activity study on ergosterol of paecilomyces hepiali |
| 03/20/2013 | CN102973956A T2 weighing magnetic resonance imaging contrast agent and preparation method thereof |
| 03/20/2013 | CN102973955A Magnetic resonance imaging contrast agent containing trivalent aluminium |
| 03/20/2013 | CN102973954A Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 03/20/2013 | CN102973949A Preparation method for alpha-TOS-loaded and dendrimer-wrapped gold nanoparticles |
| 03/20/2013 | CN102973948A Method for preparing drug carrier based on magnetic carbon quantum dot/chitosan composite microsphere |
| 03/20/2013 | CN102973518A Perfluorocarbon compound lipidosome nanosphere and preparation method thereof |
| 03/20/2013 | CN102973510A Method for preparing dual-function targeting quantum dot lipidosome |
| 03/20/2013 | CN102972345A Modeling processing method of non-alcoholic fatty liver mouse model |
| 03/20/2013 | CN102336838B Paramagnetic metal complex and synthetic method and application thereof |
| 03/20/2013 | CN102319443B Low-field high-relaxation rate magnetic resonance imaging (MRI) contrast agent and preparation method |
| 03/20/2013 | CN102234679B Preparation method of tumor detection nanoprobe |
| 03/20/2013 | CN102166503B Multifunctional polyelectrolyte microcapsule and template-free assembling method thereof |
| 03/19/2013 | CA2604150C A magnetic resonance system and method to detect and confirm analytes |
| 03/19/2013 | CA2552888C Medical devices visible under magnetic resonance imaging |
| 03/14/2013 | WO2013036974A1 Cellular uptake control systems |
| 03/14/2013 | WO2013036743A1 Imaging agents for imaging protease activity and uses thereof |
| 03/14/2013 | WO2013036543A2 Molecular imaging of cancer cells in vivo |
| 03/14/2013 | WO2013035750A1 Polymer-type fluorescent molecule probe |
| 03/14/2013 | WO2012136813A9 Agents for medical radar diagnosis |
| 03/14/2013 | US20130067605 hnRNP A1 KNOCKOUT ANIMAL MODEL AND USE THEREOF |
| 03/14/2013 | US20130067604 Method of Treatment or Prevention of Hair Loss or for the Enhancement of Hair Growth |
| 03/14/2013 | US20130067603 Sperm-specific cation channel, catsper4, and uses therefor |
| 03/14/2013 | US20130066199 Tumor margin detection method based on nuclear morphometry and tissue topology |
| 03/14/2013 | US20130066195 Device and method for safe location and marking of a cavity and sentinel lymph nodes |
| 03/14/2013 | US20130065995 Surface-Modified Tantalum Oxide Nanoparticles, Preparation Method Thereof, and Contrast Medium for X-Ray Computed Tomography and Highly Dielectric Thin Film Using Same |
| 03/14/2013 | US20130065849 Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs |
| 03/14/2013 | US20130064776 Labelled silica-based nanomaterial with enhanced properties and uses thereof |
| 03/14/2013 | US20130064775 Use of riluzole for treating or preventing the adverse effects of antineoplastic agents |
| 03/14/2013 | US20130064774 Methods and compositions for maintenance of a functional wound |
| 03/14/2013 | US20130064773 Drug-containing implants and methods of use thereof |
| 03/14/2013 | US20130064772 Infection activated wound caring compositions and devices |
| 03/14/2013 | US20130064771 Photoacoustic matching material |
| 03/14/2013 | US20130064767 Imaging infection with compounds that bind to thymidine kinase |
| 03/14/2013 | US20130064765 Antithrombotic nanoparticle |
| 03/14/2013 | US20130064763 Anti-icam-1 single domain antibody and uses thereof |
| 03/14/2013 | US20130064762 Methods of detecting and treating cancers using autoantibodies |
| 03/14/2013 | CA2851344A1 Polymer-type fluorescent molecule probe |
| 03/14/2013 | CA2848359A1 Cellular uptake control systems |
| 03/14/2013 | CA2848147A1 Compositions, methods, and systems for the synthesis and use of imaging agents |
| 03/13/2013 | EP2567234A1 Diagnostic method for the detection of cells ex vivo |
| 03/13/2013 | EP2566522A1 Imageable activatable agent for radiation therapy and method and system for radiation therapy |
| 03/13/2013 | EP2566334A1 Controlled drug release from solid supports |
| 03/13/2013 | CN1732173B High pure phthalein derivative and process for preparing the same |
| 03/13/2013 | CN102971014A Synthesis of high-performance iron oxide particle tracers for magnetic particle imaging (MPI) |
| 03/13/2013 | CN102970977A Lipid bilayer carrier for drugs or imaging agents |
| 03/13/2013 | CN102965393A Method for preparing human induced pluripotent stem cells and use of human induced pluripotent stem cells |
| 03/13/2013 | CN102961765A Preparation method of super-molecular nano fiber for magnetic resonance imaging radiography |
| 03/13/2013 | CN102961764A Gadolinium-containing macromolecular contrast agent and preparation method thereof |
| 03/13/2013 | CN102961763A Paramagnetism metal complex magnetic resonance imaging contrast agent containing asparaginic acid-glucan and preparation method of contrast agent |
| 03/13/2013 | CN102961762A Method for wrapping fluorescent protein by nanosilicon dioxide |
| 03/13/2013 | CN102961761A Quantum dot targeting probe for colorectal cancer tumor tissue identification and preparation method thereof |
| 03/13/2013 | CN102961760A Overlaping peptide taken as reagent for preparing skin tests and detecting specific cellular immune and application |
| 03/13/2013 | CN102961753A Copper sulfide/mesoporous silicon dioxide core-shell nano material as well as preparation method and application thereof |
| 03/13/2013 | CN102526767B Transporting marker for gastrointestinal tract and preparation method thereof |